Warkentin, md h eparin induced thrombocytopenia hit is an adverse drug reaction characterized by thrombocytopenia and. Riia on platelets and monocytes to propagate a hypercoagulable state culminating in lifethreatening thrombosis. American society of hematology 2018 guidelines for management of venous. Pathogenic antibodies to pf4heparin bind and activate cellular fc. If heparin is given after the procedure, monitor platelet count daily. Diagnosis of heparininduced thrombocytopenia karen a. Heparininduced thrombocytopenia diagnosis and management theodore e. However, not all thrombocytopenia is due to such system alterations. Hit predisposes to thrombosis the abnormal formation of blood clots inside a blood vessel because platelets release microparticles that activate thrombin, thereby. This reaction can destroy the patients platelets and, in the worst cases, cause clots to form in the patients blood, which is the opposite of what heparin is meant to achieve. Heparininduced thrombocytopenia hit is heparins most clinically. Heparininduced thrombocytopenia hit is a lifethreatening immune response to heparin and its derivatives that is associated with a high risk of thromboembolic complications.
The 4ts scoring system is a screening tool that accurately rules out hit. This cardiology patient page focuses on heparin induced thrombocytopenia hit, a complication of heparin therapy. Management of heparininduced thrombocytopenia uptodate. Heparininduced thrombocytopenia hit is an immune complication of heparin therapy caused by antibodies to complexes of platelet factor 4 pf4 and heparin. Heparininduced thrombocytopenia hit immune complexes heparinpf4igg cause platelet activation via the platelet fc. What diagnostic studies are warranted, and how should this patient be treated. Heparin induced thrombocytopenia hit treatment page 1 of 7 disclaimer. Hit is a clinicopathologic diagnosis where laboratory testing plays an essential role.
Smock, md associate professor of pathology, medical director, arup hemostasisthrombosis laboratory. Do not send hit antibody testing elisa or serotonin release assay sra 4. This is the case with heparin induced thrombocytopenia, or hit. Heparininduced thrombocytopenia american society of hematology. Heparin induced thrombocytopenia hit is a lifethreatening complication of exposure to heparin ie, unfractionated heparin, low molecular weight lmw heparin that occurs in up to 5 percent of patients exposed, regardless of the dose, schedule, or route of administration. Heparininduced thrombocytopenia genetic and rare diseases. Heparin induced thrombocytopenia hit is a clinicopathological syndrome that occurs when heparin dependent, igg antibodies bind to heparin platelet factor 4 pf4 complexes to activate platelets and produce a hypercoagulable state. Physicians evidencebased clinical practice guidelines 8th edition. This cardiology patient page focuses on heparininduced thrombocytopenia hit, a complication of heparin therapy. Heparin induced thrombocytopenia hit can cause an immunemediated thrombocytopenia that can lead to thrombosis, stroke, loss of limb, or other ischemic events e.
Heparin induced thrombocytopenia hit treatment page 1 of 7. Heparininduced thrombocytopenia hit is the development of thrombocytopenia a low platelet count, due to the administration of various forms of heparin, an anticoagulant. Hit typically presents with a fall in platelet count with or without venous andor arterial. Hit occurs in up to 5% of patients receiving unfractionated heparin ufh for. Hit is usually an immune response which typically occurs 410 days after exposure to heparin. Heparininduced thrombocytopenia hit is a complication of heparin therapy and is characterized by two types. American and british guidelines recommend therapeutic dose anticoagulation for 4 weeks in patients with isolated hit and 3 months for hit. Heparin induced thrombocytopenia hit is an immune igg mediated condition that occurs secondary to heparin exposure. Hit may also be associated with low molecular weight heparin use. Heparininduced thrombocytopenia thrombocytopenia induced thrombocytopenia heparin induced thrombocytopenia hit is characterized by a decrease in the platelet count of more than 50% from the highest platelet count valu. Heparininduced thrombocytopenia mild to moderate thrombocytopenia or a 50 percent reduction after exposure to heparin or lowmolecularweight heparin arterial and venous thrombosis. Smock, md associate professor of pathology, medical director, arup hemostasisthrombosis laboratory, university of utah and george m.
Guidelines from the american college of chest physicians accp28 recom mend platelet count monitoring in patients with a risk of hit that is. Heparin induced thrombocytopenia hit is an antibodymediated adverse drug reaction that can lead to devastating thromboembolic complications, including pulmonary embolism, ischemic limb necrosis necessitating limb amputation, acute myocardial infarction, and stroke. Treatment and prevention of heparininduced thrombocytopenia. Pdf heparininduced thrombocytopenia hit is a major health problem, especially in cardiac surgery theaters, cardiac catheterization labs. Heparin induced thrombocytopenia hit is an unusual immunemediated adverse drug reaction with the central paradox being its strong association with thrombosis, despite the role of an anticoagulant heparin in causing a fall in platelet count thrombocytopenia. Heparin induced thrombocytopenia hit is the development of thrombocytopenia a low platelet count, due to the administration of various forms of heparin, an anticoagulant. Heparininduced thrombocytopenia hit can cause an immunemediated thrombocytopenia that can lead to thrombosis, stroke, loss of limb, or other ischemic events. Has been described without heparin exposure associated with venous and arterial thrombosis typical previous infectious gram neg bacteria or inflammatory event pos immunoassay significant. The following guideline is intended to guide the management of heparin induced thrombocytopenia and includes recommendations for diagnosis and treatment agents. Heparininduced thrombocytopenia hit is an unusual immunemediated adverse drug reaction with the central paradox being its strong association with thrombosis, despite the role of an anticoagulant. Hit is a rare condition where a patient has a reaction to heparin. Heparininduced thrombocytopenia hit is an antibodymediated adverse drug reaction that can lead to devastating thromboembolic complications, including pulmonary embolism, ischemic limb necrosis. Heparininduced thrombocytopenia new england journal. Negatively charged heparin forms a complex with positively charged platelet factor.
Riia thrombocytopenia high risk of thrombosis occurs in 50% of untreated cases may be venous dvt, pe or arterial limb ischemia, stroke, mi thrombotic complications can be fatal. Heparininduced thrombocytopenia blood american society. Rodgers, md, phd professor of medicine and pathology, medical director, arup hemostasisthrombosis laboratory, university of utah. Heparininduced thrombocytopenia hit is a lifethreatening. Warkentin, md h eparin induced thrombocytopenia hit is an adverse drug reaction characterized by thrombocytopenia and a high risk for venous or arterial thrombosis. Physicians evidencebased clinical practice guidelines. Heparininduced thrombocytopenia is a profoundly dangerous, potentially lethal, immunologically mediated adverse drug reaction to unfractionated heparin or, less commonly, to lowmolecular weight. Heparininduced thrombocytopenia symptoms, diagnosis and.
Heparininduced thrombocytopenia hit is one of the most common fatal. Moser, md heparininduced thrombocytopenia hit is a complication seen in approximately 1%3% of patients treated with unfractionated heparin therapy. This induces the formation of antipf4 heparin igg antibodies. Heparin induced thrombocytopenia kettering health network. Solidphase enzymeimmunoassays are an objective tool for ruling out hit, but a positive test requires platelet activation tests such as the serotonin. A 63yearold man with coronary artery disease who has recently undergone bypass surgery presents with dyspnea. Heparin induced thrombocytopenia hit is considered the most common form of drug induced thrombocytopenia as well as one of the common causes of thrombocytopenia in hospitalized patients. Heparin induced thrombocytopenia mild to moderate thrombocytopenia or a 50 percent reduction after exposure to heparin or lowmolecularweight heparin arterial and venous thrombosis. Heparin induced thrombocytopenia hit is a known complication of heparin exposure. Pathogenic antibodies to pf4 heparin bind and activate cellular fc. The 4ts for the diagnosis of heparin induced thrombocytopenia hit is a tool developed to help clinicians rule out hit in patients who develop thrombocytopenia in the clinical setting. Hit is caused by formation of immunoglobulin g antibodies that recognize complexes of platelet factor 4 pf4 and heparin and activate platelets resulting in mild to moderate thrombocytopenia platelet count thrombocytopenia is a serious condition in which patients have a low platelet count. May 03, 2012 heparin induced thrombocytopenia hit is an adverse reaction to the drug heparin resulting in an abnormally low amount of platelets thrombocytopenia. Included patients being evaluated for thrombocytopenia or suspected hit in two clinical settings.
This algorithm has been developed for md anderson using a multidisciplinary approach considering circumstances particular. Heparin induced thrombocytopenia hit is an immunemediated, prothrombotic disorder caused by plateletactivating antibodies of igg class that recognize multimolecular complexes consisting of a positively charged chemokine, platelet factor 4 pf4, bound to negatively charged heparin or certain other plateletassociated. Heparin induced thrombocytopenia hit is a complication of heparin therapy and is characterized by two types. The primary clinical presentation of hit is thrombocytopenia, usually with a.
Hit results from an interaction between negatively charged heparin and a. Heparin induced thrombocytopenia hit is a syndrome of platelet activation, thrombocytopenia, and thrombosis that occurs in 15% of patients who receive heparin. Key clinical pointsheparininduced thrombocytopenia heparininduced thrombocytopenia hit is characterized by a decrease in the platelet count of more than 50% from the highest platelet count valu. The most commonly used intravenous anticoagulant is heparin. Some patients with hit develop serious thrombotic complications like limb. Negatively charged heparin forms a complex with positively charged platelet factor 4 pf4 1. Heparininduced thrombocytopenia hit is an immune igg mediated condition that occurs secondary to heparin exposure. Heparininduced thrombocytopenia thrombocytopenia aug 01, 2000 heparin induced thrombocytopenia hit is a wellknown complication of heparin therapy. This can occur due to certain disease processes such as alterations in the immune system or with leukemia. Two clinical forms of hit are generally recognized.
Heparin induced thrombocytopenia hit is a serious complication of heparin therapy that has a high rate of morbidity thrombosis and amputation and mortality. Because the platelet count normalizes even with continued heparin therapy, it is not associated with increased thrombotic risk. Moser, md heparininduced thrombocytopenia hit is a complication seen in approximately 1%3% of patients treated with unfractionated heparin. Guidelines on the diagnosis and management of heparininduced thrombocytopenia. Heparininduced thrombocytopenia hit is an adverse prothrombotic disorder caused by an immune response to complexes of platelet factor 4 and polyanions. Heparin induced thrombocytopenia hit is a lifethreatening immune response to heparin and its derivatives that is associated with a high risk of thromboembolic complications. Has been described without heparin exposure associated with venous and arterial thrombosis typical previous infectious gram neg bacteria or inflammatory event pos immunoassay significant inflammatory response causing activation of pf4 without need for heparin, causing platelet activation non heparin polyanions causing activation of pf4.
Heparininduced thrombocytopenia hit is an immunemediated, prothrombotic disorder caused by plateletactivating antibodies of igg class that recognize multimolecular complexes consisting of a. In the past, a number of different anticoagulants have been used to treat hit in an attempt to prevent these complications. Guidelines on the diagnosis and management of heparin. Heparininduced thrombocytopenia hit is a syndrome of platelet activation, thrombocytopenia, and thrombosis that occurs in 15% of patients who receive heparin. Heparininduced thrombocytopenia hit is an adverse reaction to the drug heparin resulting in an abnormally low amount of platelets thrombocytopenia. Heparininduced thrombocytopenia blood american society of. Target population adult patients with suspicion or diagnosis of heparin induced thrombocytopenia key practice recommendations screening for hit 1. Hit is an antibodymediated disorder of coagulation caused by exposure to heparin and associated with significant risk of thromboembolic complications and death 1,2,3. The 2012 accp clinical guidelines recommend treating hit and hitt with the nonheparin anticoagulant agents lepirudin, argatroban, and. Laboratory testing reveals a platelet count of 86,000 per cubic millimeter, as compared with 225,000 per cubic millimeter at the time of discharge nine days earlier.
Heparininduced thrombocytopenia hit is a lifethreatening complication of exposure to heparin ie, unfractionated heparin, low molecular weight lmw heparin that occurs in up to 5. Heparininduced thrombocytopenia is a profoundly dangerous, potentially lethal, immunologically mediated adverse drug reaction to unfractionated heparin or, less commonly, to lowmolecular. Heparininduced thrombocytopenia heparininduced thrombocytopenia hit is characterized by a decrease in the platelet count of more than 50% from the highest platelet count value after the start of heparin, an onset 5 to 10 days after the start of heparin, hypercoagulability, and the presence of heparindependent, plateletactivating igg. Heparininduced thrombocytopenia is a profoundly dangerous, potentially lethal, immunologically mediated adverse drug reaction to unfractionated heparin or, less commonly, to lowmolecular weight heparin. Heparininduced thrombocytopenia hit is an antibodymediated adverse drug reac tion that can lead to devastating thromboembolic complications, including pulmonary embolism, ischemic. Heparin induced thrombocytopenia hit is an adverse prothrombotic disorder caused by an immune response to complexes of platelet factor 4 and polyanions.
This complication of heparin is often confusing because in hit, heparin does the opposite of what it is supposed to do. Heparininduced thrombocyto penia hit is an adverse drug reaction characterized by thrombocytopenia and a high risk for venous or arterial thrombosis. This algorithm has been developed for md anderson using a multidisciplinary approach considering circumstances particular to md andersons specific patient population, services and structure, and clinical information. Heparin induced thrombocytopenia hit is an antibodymediated adverse drug reac tion that can lead to devastating thromboembolic complications, including pulmonary embolism, ischemic limb necrosis necessitating limb amputation, acute myocardial infarction, and stroke. Heparin induced thrombocytopenia adult inpatient clinical. Heparininduced thrombocytopenia hit is considered the most common form of druginduced thrombocytopenia as well as one of the common causes of thrombocytopenia in hospitalized patients.
1301 401 1560 506 998 1074 1564 1628 1095 679 655 1381 366 931 123 93 1368 269 1248 1439 622 853 70 923 1144 342 1653 485 310 1085 862 1230 1467 1048 506 1249 1200